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Abstract
Background: Young mothers living in low-income urban settings often are exposed to significant and chronic
environmental difficulties including poverty, social isolation and poor education and typically also have to cope
with personal histories of abuse and depression. Minding the Baby® (MTB) is an interdisciplinary home-visiting
programme developed to support first-time young mothers, which integrates primary care and mental health
approaches into a single intensive intervention from the last trimester of pregnancy until the child’s second
birthday. The primary aim of the intervention is to promote caregiver sensitivity, and, secondarily, to promote
both child and maternal socioemotional outcomes.
Methods/design: This is a multisite randomised controlled trial (RCT) with a target recruitment of 200 first-time
adolescent mothers (under 26 years of age). One hundred participants will be randomised to the MTB group
and they will receive the MTB programme in addition to the usual services available in their areas. Those
participants not allocated to MTB will receive Treatment as Usual (TAU) only. Researchers will carry out blind
assessments at baseline (before the birth of the baby), and outcome assessments around the child’s first and
second birthdays. The primary outcome will be the quality of maternal sensitivity and the secondary outcomes
will focus on attachment security, child cognitive/language development, behavioural problems, postponed
childbearing, maternal mental health and incidents of child protection interventions.
Discussion: This study evaluates the Minding the Baby® programme in the UK. In particular, this RCT explores
the effectiveness of this integrative approach, which focusses on maternal mental issues as well as parent-infant
interaction, parental concerns and developmental outcomes.
Trial registration: ISRCTN08678682 (date of registration 3 April 2014).
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Background
Overview and rationale
The NSPCC, in collaboration with University College
London, the University of Reading, the Yale Child Study
Centre and the Yale School of Nursing, is initiating a
multisite study of the effectiveness of a targeted preven-
tion programme that incorporates well-established
principles of home visiting with a more comprehensive
package of care for the developing mother-infant relation-
ship. The programme represents an important opportun-
ity to advance the UK’s provision of evidence-based
support for at-risk families and to intervene effectively in
the intergenerational cycle of disadvantage. The Minding
the Baby® (MTB) programme is an interdisciplinary inter-
vention that was developed and tested by a team of
researchers and clinicians at the Yale Child Study Centre
and the Yale School of Nursing [1]. MTB combines many
of the benefits of home-visiting programmes – particularly
their relative cost-effectiveness, client acceptability and
accessibility – with a coherent, evidence-based clinical
dimension that is informed by, and directly targets, well-
studied mechanisms of risk in early child development. In
focussing on key domains of parent-child relationships
where disturbances are known risk factors for later child
maladjustment, particularly the sensitivity of parental care,
the security of infant-parent attachment and the parent’s
capacity to reflect on the child as an autonomous agent
with needs, feelings and thoughts, the programme aims
to combine best clinical practice in early prevention
with scientific evidence regarding the developmental
processes that promote optimal child outcomes. Cur-
rently, the UK health and social care systems offer a
range of services to young families targeting mental
health or promoting family relationships from birth,
which are not always evidence-based and vary consider-
ably from region to region. Home-visiting programmes
are characterised by the presence of consistent and reli-
able support figures with high-quality training who are
capable of addressing a broad range of parenting con-
cerns from the practical to the emotional [2]. The highly
influential Nurse Family Partnership (NFP) model is a
well-known example that has been found to be effective
for several important early child and maternal out-
comes [3]. A notable limitation of existing home-
visitation programmes, however, is the relative lack of
focus on supporting parent-child interaction and par-
ticularly attachment. This is a central target of MTB
[4, 5]. Longitudinal outcome studies clearly show that
disturbances in the quality of care can have lasting
negative consequences for children’s development, and
the long-term social and financial costs associated
with these poor outcomes are likely to be considerable
[6]. The potential value of effective early intervention
focussed on sensitivity of care, particularly for parents
experiencing multiple social adversities, therefore,
cannot be overstated.
This randomised clinical trial will test the hypothesis
that an intensive home-visiting programme focussed on
promoting young parents’ sensitive attunement to their
infants and their ability to mentalise on their baby’s
thoughts, feelings and needs, will lead to improvements
in the sensitivity of parenting of children age 2 years
compared to parents who receive routine care. The
study will also examine several secondary hypotheses, in-
cluding that the programme will increase offspring rates
of secure attachment, improve cognitive and behavioural
outcomes and promote maternal mental health.
Background and significance
Although rates of teenage pregnancies have been drop-
ping in the UK over the last 10 years, it remains the
case that such pregnancies are greatly over-represented
in low-income urban populations [7]. The many envir-
onmental stressors that these young parents face (pov-
erty, single parenthood, social isolation and poor
educational achievement [8]) are often amplified by
personal histories of abuse, depression and posttrau-
matic stress disorder (PTSD) [9, 10]. These parents
may find themselves not only having to deal with their
own developmental needs but also trying to take on the
complex roles and responsibilities of parenting. It is
perhaps not surprising that young parents living in
these circumstances are more susceptible to mental
health problems and may struggle to become respon-
sive nurturing parents [11, 12]. Social disadvantage
more generally represents a broad but very reliable
marker of a host of contextual, psychological and devel-
opmental risk factors that have well-established nega-
tive impacts on the quality of parenting and on child
development [13–15]. The MTB programme is aimed
at supporting young parents facing multiple social
stressors, and raising their first infant in adverse social
circumstances, in order to promote positive parenting,
raise rates of secure attachment and improve child de-
velopmental outcomes.
The MTB programme is the result of an interdisciplin-
ary collaboration between the Yale School of Nursing
and the Yale Child Study Centre. MTB is an intensive
and preventive home-visitation programme for young
first-time parents. MTB primarily evolved from two
home-visiting models that originated in the US; the NFP
and the infant-parent psychotherapy model. David Olds
and colleagues developed the NFP programme [3],
which involves home visits by highly trained nurses to
vulnerable high-risk first-time mothers. Home visits
begin at the end of the second trimester of pregnancy
and continue through the child’s second birthday. Exten-
sive research on the effectiveness of the NFP programme
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in high-risk populations showed improved health, parent-
ing and developmental outcomes [2, 3, 16–23]. A different
emphasise is on the infant-parent psychotherapy model
which was developed to protect infants and help parents
with mental health problems, often as a result of ongoing
trauma. Although this model has been less rigorously
tested than the NFP programme, positive child outcomes
were found. In particular, this programme appears to
supports the development of healthy mother-child rela-
tionships and secure attachment [24], both of which are
prognostic indicators of longer-term positive develop-
mental outcomes in the child [25].
The MTB programme brings together both these
models, providing a holistic intervention that not only
addresses maternal mental health issues but also health,
attachment and life course outcomes for mother, child
and family. Thus, MTB aims to bring together health,
developmental, attachment and mental health approaches.
By incorporating both nursing and mental health ap-
proaches, MTB serves to address some of the more com-
plex needs of mothers and families at risk.
Attachment and Reflective Functioning
It is firmly established in the attachment field that the
quality of the infant’s attachment to their primary care-
giver is robustly related to a range of child outcomes
[5]. MTB builds on this evidence and makes the pro-
motion of secure attachment a primary clinical object-
ive as a means of bringing about positive changes in
the infant’s social, emotional and cognitive develop-
ment. Originally, Ainsworth and colleagues [26] sug-
gested that a mother’s ability to respond sensitively to
her child’s cues would be crucial for the development
of secure mother-infant attachment. Later research
[27] empirically tested this hypothesis and found broad
support for the role of sensitivity in secure attachment.
Furthermore, recent work has highlighted the role of
the mother’s own mental state with respect to attach-
ment – referred to as her internal working model
(IWM) of attachment, in shaping the sensitivity of care,
and thus her child’s attachment security [28]. These
attachment representations are thought to shape how a
parent perceives their child and, accordingly, how they
respond to the child’s behaviour, cues and communica-
tions [29].
A critical feature of the way in which parents think
about their children is their ability to consider the
child’s thoughts, feelings and beliefs, and to treat the
child, therefore, as an individual with a mind. Crucially,
research indicates that this ability not only to think of
the child as an individual with their own thoughts and
feelings, but also to understand and make a causal connec-
tion between the child’s behaviours and their underlying
feelings and experiences, is crucial in the development of a
secure attachment [30]. This capacity has been termed by
Fonagy and colleagues as ‘mentalisation’ or ‘Reflective
Functioning’ (RF) [31]. Slade and colleagues’ research in
this area has demonstrated consistent relationships be-
tween a mother’s ability to mentalise, maternal behaviour,
and child attachment [30, 32].
The MTB programme is rooted in this developmental
theory and, at its core, the MTB programme aims to in-
crease the parent’s capacity to think about their child
and reflect upon their thoughts, and feelings, and to re-
spond in a sensitive and attuned way to the child’s cues
and communications.
Minding the Baby®: an interdisciplinary approach
The home-visiting intervention programmes presented
above have mostly focussed on either the practical as-
pects of parenting or the quality of the mother-child
relationship and attachment. MTB aims to address
both these elements of parenting.
The UK MTB clinical team includes two qualified
practitioners: a nurse or health visitor and a social
worker who are both highly trained and supervised in
particular techniques and developmental approaches tai-
lored for working with vulnerable young mothers. The
nurse provides advanced levels of practical parenting
support including individual and family health assess-
ments, nutritional advice and family planning. The social
worker provides mental health support to mother and
baby, in-home assessment and intervention for mild to
moderate mental health problems like depression, anx-
iety and PTSD symptoms that the mother might be af-
fected by. Crucial to the success of the MTB programme
is the mother’s relationship with the MTB practitioners.
Their engagement and fostering of ongoing relationships
with these at-risk, first-time young mothers, as well as
having the professional expertise that matches their
complex health, social and mental health needs, is aimed
to diminish attrition from the programme. This kind of
integrative model is considered to be crucial for maxi-
mising both parental and child outcomes across a range
of domains.
Following the Yale model, the UK MTB is grounded
in well-established developmental research, builds on
the experience of similar successful programmes, is a
relationship-based model, delivers a flexible model of
care design to match the varying and often complex
needs of at-risk families, and has a robust, manualised
system of training and supervision.
Aims and objectives
Aim 1: the primary aim of this study is to test whether
participation in the MTB programme leads to improve-
ments in the quality of parenting and specifically the
degree of maternal sensitivity.
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Aim 2: the secondary aims of the study are to measure
the effects of the MTB programme in relation to (1) ma-
ternal outcomes including maternal mental health, mater-
nal RF and postponed subsequent child bearing and (2)
infant outcomes including incidents of child protection
intervention, attachment security to the parent, cognitive
and language development and behavioural problems.
Aim 3: a further key secondary aim is to assess the
cost benefit/cost-effectiveness of the MTB programme
in order to sustain future programmes.
Methods
Design
This is a multisite randomised controlled trial, with ran-
domisation at the case level. This trial will utilise a two-arm
design, with random allocation to either MTB plus Treat-
ment as Usual (TAU) or a TAU-only control condition.
Allocation will be by minimisation, controlling for maternal
age, maternal depression and study site. Figure 1 shows a
flow diagram of the study design, and the Standard Proto-
col Items: Interventions for Reporting Trials (SPIRIT)
checklist is presented in Additional file 1 [33, 34].
Outcome measures
Primary outcome
The primary outcome is the quality of parenting, operatio-
nalised as maternal sensitivity [26]. Maternal sensitivity
will be measured at ages 1 and 2 years and will be treated
as a continuous score, with both time points included in
the primary analysis.
In order to measure parenting sensitivity at ages 1 and
2 years, we will use several short tasks from our existing
studies of attachment and another ongoing clinical trial.
The first task focusses on mother-infant interaction in
the context of free-play. Known as the ‘three-boxes pro-
cedure’, the mother shows the child experimenter-
provided toys in three containers in a set order [35–37].
The second is a procedure pioneered by Smith and
Pederson [36]. In this task, mother and infant are left
to explore a relatively empty room, while the mother
must also complete a distraction questionnaire. An-
other task involves brief observations, one focussing on
book-sharing and the other on a difficult-to-manipulate
toy. Finally, we are using a separate joint book-reading
observation in which the content of the book involves
strong attachment-related scenarios. In each case, ma-
ternal sensitivity will be rated, using Emotional Avail-
ability Scales [38], an observation tool. The scales
describe and assess four dimensions on the adult side
(sensitivity, structuring, nonintrusiveness and nonhosti-
lity) and two dimensions on the child side (responsive-
ness and involvement with the caregiver). Dimensions
are measured on a scale, with scores of between 1 and 7.
Scales will be standardised and summed to yield a total
Fig. 1 Flow diagram of the study design
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score across all tasks for the main analysis. The use of spe-
cific contexts for mother-infant interactions will also allow
us to determine whether the intervention is changing the
particular processes associated with each domain of child
development in tertiary analyses.
Secondary outcomes
Child attachment security, measured with the Attach-
ment Q-Set (AQS: [39]), which will be administered at
year 2. The AQS is based on a set period of observation
of children aged 1–5 years in the home environment.
The AQS consists of a set of 90 cards with a specific
behavioural characteristic described on each card that is
age-appropriate. The cards are used as a standard vo-
cabulary to describe the behaviour of a child in a home
setting, with an emphasis on secure-base behaviour. The
researcher who has observed the parent and child ranks
the cards into several piles from ‘most descriptive of the
subject’ to ‘least descriptive of the subject’. The Q-Set
provides a score along a continuum of secure to inse-
cure. The Q-Set has shown good convergent and dis-
criminate validity [40] and is a strong predictor of later
developmental outcomes [41].
Child cognitive and language development will be
assessed at year 2 using the Bayley Scales of Infant and
Toddler Development, third edition (Bayley-III) [42].
The Bayley-III is an individually administered assess-
ment that evaluates the child’s mental and motor devel-
opment. The scales are administered when children are
between the ages of 2 months and 42 months. This
yields two separate continuous scales representing over-
all cognitive development and language development.
The Bayley-III is a standardised instrument and the cogni-
tive scales and language composite correlate, respectively
(r = .79) and (r = .82), with the WPPSI-III Full-scale IQ
(Weschler Preschool and Primary Scale of Intelligence),
reported for children aged 28–42 months. Bayley-III is
also UK-validated [43].
Behavioural problems will be assessed with the Child
Behaviour Checklist (CBCL: [44]) questionnaire at year
2. This consists of a 100-item parent-report question-
naire and is valid for children from 18 months and older.
The CBCL measure yields three age-normed scales of
Internalising Problems (i.e. anxious, depressive, and
over-controlled), Externalising Problems (i.e. aggressive,
hyperactive, noncompliant, and under-controlled) and
Total Problems. Parents record responses with: 0 (Not
true, as far as I know), 1 (Somewhat or Sometimes true)
or 2 (Very true or Often true). The analysis will focus
on the Total Problem scale. The CBCL is one of the
most widely-used standardised measures in child
psychology for evaluating maladaptive behavioural and
emotional problems [45].
Postponed child-bearing will be assessed at each
follow-up when mothers will be asked about their preg-
nancy status. The number of months from baseline to
the next pregnancy will be used for analysis.
Maternal mental health will be measured with the
Edinburgh Postnatal Depression Scale (EPDS: [46])
questionnaire which will be administered at baseline,
year 1 and year 2. The EPDS is a 10-item questionnaire
screening for postnatal depression. Mothers’ responses
are on a scale of 0 to 3, and a score is calculated adding
individual items. All three total scores from the ques-
tionnaire will be entered into the analysis, with change
from baseline being the outcome of interest. EPDS is a
well-validated measure of depression [47] that may be
used within 8 weeks postpartum but has also been ap-
plied for depression screening during pregnancy [48].
Child Quality of Life will be assessed at year-1 and
year-2 follow-ups with the Warwick Child Health and
Morbidity Profile (WCHMP) questionnaire [49]. This
consists in a 10-item survey where parents are asked to
report on health and morbidity in infancy and child-
hood. The WCHMP has shown to be reliable and valid
with low interobserver variation [49]. An incremental
cost-effectiveness ratio (ICER) will be calculated and the
two groups of mothers compared.
Health and social care resource use will be collected
throughout the study using the Service Use and Sup-
ports Questionnaire (SUS) [50]. This is a self-report
questionnaire administered at baseline and every subse-
quent follow-up, i.e. 6 months, year 1, 18 months and
year 2. Mothers are asked to note whether they had any
input from professionals and voluntary agencies in the
previous 6 months, in four areas: (1) health services, (2)
mental health services, (3) support services and (4) child
care services. Parents are also asked to note down the
single most helpful service they have accessed over the
previous 6 months. Costs are applied to service use at
each time point. Total costs per patient will be calcu-
lated from the total across all follow-up points and ad-
justed for by baseline values. Unit costs will be obtained
from the Personal Social Services Research Unit’s
(PSSRU) nationally published reference costs and pub-
lished studies.
Additional outcome measures
Infant Behaviour Questionnaire Revised (IBQ-R: [51]) is
a parent-report questionnaire that ask parents to rate
the frequency of specific temperament-related behav-
iours observed over the past week (or sometimes
2 weeks). The IBQ-R assesses the child’s temperament
on six dimensions including activity level, soothability,
fear, smiling and approach behaviours. Parents rate the
frequency of specific temperament-related behaviours on
a scale of 1 to 7. The IBQ-R has demonstrated good
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internal consistency, reliability and convergent validity
[52]. The IBQ-R will be administered at year 1.
Infant Health Outcome data will be collected at the end
of the study through a review of the infant’s/toddler’s
health records. Data will be collected on birth outcomes,
routine hospital visits, completeness of immunisations,
accident and emergency (A&E) visits, presence of chronic
health problems and number of referrals to Social Services.
Unit costs will be applied to calculate the cost per infant.
Maternal Sense of Mastery is measured by the Pearlin
and Schooler 7-item scale. Women are asked to measure
the degree to which they perceive they can control their
life’s chances [53]. Responses are based on a 7-item scale
(agreement to disagreement), and higher scores reflect
greater level of mastery. This scale has been used exten-
sively with similar samples of young women [54]. It will
be administered at baseline, 1- and 2-year follow-ups.
Norbeck Social Support Questionnaire (NSSQ: [55, 56])
measures multiple functional dimensions of social sup-
port: (1) affect, (2) affirmation and (3) aid. Participants
are instructed to list first names or initials for each sig-
nificant person in their lives who provides personal
support to them. Participants are asked to identify their
relationship with the individual and finally to use a 5-
point rating scale to describe the amount of support
available from each person. The NSSQ has shown to be a
valid and reliable measure of all three functional types of
social support as well as total network support [57]. It will
be administered at baseline, 1- and 2-year follow-ups.
Parent Development Interview – Revised (PDI: Slade
A, Aber JL, Bresgi I, Berger B, Kaplan M. The Parent
Development Interview - Revised. The City University of
New York, 2004. Unpublished Manuscript.) is a 20-
question interview that assesses parents’ representations
of their child, their relationships with them, and par-
ticularly their capacity to reflect on their child’s mental
states. Transcribed interviews are scored for RF. Initial
studies testing the validity of this measure have linked
it to adult attachment, child attachment and parental
behaviour both in normal and drug-using samples [4,
29, 32, 58–60]. RF is scored on a scale of 1–9 with
higher scores indicating greater levels of RF. It will be
administered at year 1.
Parenting Stress Inventory (PSI) Short Form [61] is a
36-item questionnaire that measures stress levels experi-
enced within the parenting role. Rated on a 5-point scale
(agreement to disagreement), the measure contains three
subscales pertaining to parenting stress. The PSI Short
Form (PSI-SF) subscales have demonstrated concurrent
validity with the full-length PSI [62]. The PSI-SF will be
administered at baseline, 1- and 2-year follow-ups.
PTSD Checklist-Civilian (PCL-5: [63]). This is a 20-
item PTSD screen that is closely based on the Diagnostic
and Statistical Manual of Mental Disorders, fifth edition
(DSM-V) criteria for PTSD. Participants rate each item
from 0 (not at all) to 4 (extremely) to indicate the degree
to which they have been bothered by the index symptom
in the past month. The PCL-C has shown good psycho-
metric properties, high rates of internal consistency,
test-retest reliability and is highly correlated with other
measures of trauma symptoms [64]. It will be adminis-
tered at baseline, 1- and 2-year follow-ups.
State-Trait Anxiety Inventory (STAI: [65]) is a 40-
item questionnaire that uses a 4-point Likert scale to
address both state and trait anxiety. The construct and
concurrent validity of the measure has been robustly
demonstrated [65, 66]. It will be administered at base-
line, 1- and 2-year follow-ups.
Adult quality of life (QoL) – The EuroQol EQ-5D 3
level (EQ-5D-3 L) is a health-related questionnaire
assessing the quality of life through five dimensions (mo-
bility, self-care, usual activities, pain/discomfort, anxiety/
depression). Each dimension is scored by choosing one
of three responses. The responses recorded are based
on levels of severity (no problems/some or moderate
problems/extreme problems). Utility scores will be calcu-
lated for each mother at each time point based on the
algorithm developed by Dolan [67]. Utility scores at each
time point will be used to calculate total quality-adjusted
life years (QALYs) for the duration of the trial calculated
as the area under the curve adjusting for baseline. It will
be administered at baseline, 1- and 2-year follow-ups.
Treatment Experience Questionnaire (TEQ). This is a
15-item feedback questionnaire based on questionnaires
used for similar studies (e.g. [68, 69]. This will be given
to participants in the MTB arm of the trial only, to rec-
ord satisfaction with the service they have received. Par-
ents are asked to rate the treatment on a 5-point scale
(disagreement to agreement). It will be administered at
the year 1 and year 2.
Father outcome measures. Where possible we aim to
collect selected outcome measurements from fathers at
baseline, year-1 and year-2 follow-ups. Some of the out-
come measures used for the mothers will also be used
for the fathers: quality of life (i.e. EQ-5D); mental health
(i.e. EPDS, STAI and PCL-5), support and personal net-
work (i.e. NSSQ), and paternal competence (i.e. SM and
PSI), and the Treatment Experience Questionnaire
(TEQ) for fathers in the MTB group. In Table 1 mother
and child outcome measures are summarised and the
time points of their administration reported.
Sample size
A minimum of 200 participants (100 in each arm) will
enter into the evaluation. The sample size calculation is
motivated by the effect size estimates on the primary
outcome (maternal sensitivity) and the attachment out-
come at 1 year.
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Power analysis
We based our power analyses on previous interventions
aimed at improving parenting sensitivity. The overall
meta-analytic average for sensitivity-focussed interven-
tion trials in Bakermans-Kranenburg’s (2003) review was
d = .44 which is equivalent to a correlation of r = .22. If
we assume four covariates and a single df test of
treatment effect, with a reduced model R2 of .15 and a
full model R2 of .20, then 129 participants would be
required for 80 % power at alpha = .05. Bakermans-
Kranenburg further reported that the meta-analytic aver-
age of randomised studies was d = .36 (r = .18), which for
the equivalent analysis and power would require a
sample size of 190. We also computed power to detect
Table 1 Outcome measures: description and validity of measures as well as time points of their administration
Outcome measures Description of and validity of measures Time points
Primary outcomes
Maternal sensitivity Emotional Availability Scales (EA). Observation of behaviours. Score 6 dimensions
on a 1 to 7 scale. Validated for international use [79]
Year 1 and year 2
Secondary outcomes
Child attachment security Attachment Q-Set (Q-Set). Observation of behaviours. Score on a continuum of
secure to insecure. Good convergent and discriminate validity [40]
Year 2
Child cognitive and
language development
Bayley Scales of Infant and Toddler Development Scales, third edition (Bayley-III).
Individual administration. Continuous scales produce scores. Validated for UK
and Ireland use [43]
Year 2
Behavioural problems Child Behaviour Checklist (CBCL).100-item questionnaire. Responses are on a scale
of 0 to 2. Validated for international use [45]
Year 2
Postponed child-bearing Mother asked about her pregnancy status. Number of months from baseline to
the next pregnancy used for analyses. Extensive use with similar studies (e.g. [1])
6 months, year 1, 18 months
and year 2
Maternal mental health Edinburgh Postnatal Depression (EPDS).10-item questionnaire. Responses are on
a scale of 0 to 3. Validated measure of depression [47]
Baseline, year 1 and year 2
Child quality of life (QoL) Warwick Child Health and Morbidity Profile (WCHMP). 10-items survey.
An incremental cost-effectiveness ratio (ICER) calculated. Validated with low
interobserver variation [49]
Year 1 and year 2
Health and social care
resource use
Service Use and Support (SUS). 36-item questionnaire. Cost of services calculated
with the Personal Social Services Research Unit (PSSRU). Extensive use in clinical
studies (e.g. [80])
Baseline, 6 months, year 1,
18 months and year 2
Additional outcome measures
Measurement of
temperament
Infant Behaviour Questionnaire Revised (IBQ-R). 37-item questionnaire. Responses
are on a scale of 1 to 7. Good internal consistency reliability and convergent
validity [52]
Year 1
Sensitivity scale Maternal and paternal Sense of Mastery (MSM). 7-item questionnaire. Responses
are on a 7-item scale (agreement to disagreement). Extensive use with similar
sample of young women [53]
Baseline, year 1 and year 2
Social support Norbeck Social Support questionnaire (NSSQ). 9-item questionnaire. Responses are
on a scale of 0 to 4. Validity and reliability on all measures [57]
Baseline, year 1 and year 2
Infant health outcome Health records reviewed at the end of the study and data collected on different
issues, including hospitalisation and Social Services’ referrals. Extensive use with
similar studies (e.g. [1])
Year 1 and year 2
Parental representation
of their child
Parent Development Interview – Revised (PDI). 20-item interview. Scores are on a
scale of 1 to 9. Validity shows links to adult attachment and child attachment
[29, 32, 58, 59]
Year 1
Stress within the parenting role Parental Stress Inventory Short Form (PSI-SF). 36-item questionnaire. Responses
are on a 5-point scale (agreement to disagreement). Short Forms show
concurrent validity with the full-length PSI [62]
Year 1 and year 2
PTSD Checklist Civilian Posttraumatic stress disorder (PCL-5). 20-item questionnaire Responses are on a
scale of 0 to 4. PCL-5 has good psychometric properties [64]
Baseline, year 1 and year 2
State and trait anxiety State-Trait Anxiety Inventory (STAI). 40-item questionnaire. Responses are on a
scale of 0 to 4. Strong construct and concurrent validity [65, 66]
Baseline, year 1 and year 2
Adult quality of life (QoL) EuroQol EQ-5D 3 level (EQ-5D-3 L) 6-item questionnaire. Responses are on a
scale of 0 to 2. Extensive use for similar study (e.g. [81, 82])
Baseline, year 1 and year 2
Treatment experience Treatment Experience Questionnaire (TEQ). 15-item questionnaire. Responses are
on a 5-point scale. Based on questionnaires used in similar studies [68]
Year 1 and year 2
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effects on attachment security. We estimated the effect
size based on meta-analytic data, based on the assump-
tion that the MTB intervention would be effective in
enhancing parental sensitivity: such studies yield average
effect sizes of d = .45 in the aforementioned meta-
analysis [70] and hence the power for this outcome
would be equivalent or greater to that for sensitivity.
Recruitment
Recruitment will take place at three UK sites: York,
Sheffield and Glasgow. Participants in York and Sheffield
will be screened if they live within a defined geographical
area around each site of approximately 15 miles of the
city centre (the precise geographical boundaries will vary
in each site).
Consent
Overview
Formal consent into this study will be taken by a mem-
ber of the research team. Prior to this, consent to be
contacted by the research team will be obtained by re-
search midwives in antenatal clinics, by health, social
care or voluntary sector professionals or provided by in-
terested families directly.
Consenting procedures
Primary entry-point into the study
At all three sites potentially eligible expectant mothers
will be informed about the MTB Study during an ante-
natal appointment in the hospital or in the community.
During this appointment expectant mothers will be
given a Participant Information Sheet and a contact leaf-
let and a research midwife or member of the antenatal
care team will provide a brief explanation of the study.
Potential participants will then be followed up by a re-
search midwife who will check eligibility, provide them
with written information about the study again (Partici-
pant Information Sheet and a ‘contact leaflet’) and will
verbally explain their involvement. This will usually be
done in person at the 20-week scan appointment, but
may also be done by telephone (with written material
sent by post) or during another antenatal appointment.
If expectant mothers are then happy to consent to be
contacted by the research team, this will be obtained
verbally, and formal written consent to participation in
the study will be obtained by the research team during
an initial home visit.
During the research home visit the researcher will ex-
plain the study in detail, answer any further questions
they might have, and, if they are willing to take part, ob-
tain their full written consent. At this research appoint-
ment baseline assessments will be carried out for all
consenting participants.
Alternative entry-points into the study
At all three sites, posters, contact leaflets and Patient In-
formation Sheets will be placed in antenatal waiting
rooms so that expectant parents can read about the
study while they wait for their antenatal appointment.
Families who are interested in taking part in the study
may self-refer by filling in a contact leaflet and leaving it
in a designated box which will be provided at the clinic.
These forms will then be collected by the research mid-
wives, and passed to the research team who will then get
in touch to arrange a visit, following the same informed
consent procedures described above. Similar contact
leaflets and Participant Information Sheets will also be
distributed to community midwives and other health,
social care and voluntary-sector professionals (e.g. GPs,
local authority housing officers, Shelter) in the area so
that if they know of mothers meeting the eligibility cri-
teria they can make them aware of the study. Such
mothers would be directed to the research team’s con-
tact telephone number, or contact leaflets can be sent to
the research team, who will then call the participant.
Professionals working with families, having obtained ver-
bal consent, may also contact the research team on be-
half of the family. Once the research team has obtained
confirmation of a participant’s wish to be contacted, the
research team would then arrange an initial visit, where
the expectant mother would be informed about the
study, given an opportunity to ask questions and con-
sented in the standard way described above.
Sheffield and Glasgow sites
FNP is offered as a clinical service to all mothers under
the age of 20 at the Sheffield and Glasgow sites. Both
FNP and MTB have similar entry criteria and a similar
set of intervention procedures and as such it will not be
possible for parents to be involved in both programmes.
As mentioned above, participants will be recruited to
the MTB trial at their 20-week scanning appointment.
Both Sheffield and Glasgow FNPs enroll parents into the
programme up until 20 weeks’ gestation and, as such,
the MTB trial will not interfere with client accessibility
to the FNP treatment. However, participants will be
excluded if they are receiving services from the FNP.
This criterion is necessary to ensure the integrity of the
TAU arm of the trial. Participation in the FNP will be
recorded in the mother’s notes, so that the research mid-
wife is able to selectively recruit non-FNP participants.
Eligibility criteria
1. Inclusion:
 Women expecting their first baby and
 Aged 19 years or under or aged between 20 to
25 years and any of the following: (1) currently
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eligible for means-tested benefits (or someone
they live with and depend upon, such as a partner
or parent, is eligible for means-tested benefits),
(2) not entitled to employer maternity pay and
(3) living in a postcode falling within the highest
quintile of social deprivation as defined by
national government statistics or living in
sheltered accommodation
2. Exclusion
 Expectant mothers with a psychotic illness
 Expectant mothers with substance abuse
disorders/chronic drug dependence
 Expectant mothers with profound or severe
learning disabilities
 Expectant mothers who would require the use
of an interpreter
 Expectant parents with a life-threatening illness
 Expectant parents whose baby is expected to
be born with a life-threatening illness or
profound disability
 The expectant mother has been accepted in
a FNP service (see ‘Recruitment’ above)
Scope of consent to participation
Consent Forms signed by the mother will include per-
mission to access health and social care records,
remaining in effect for 3 years (with the provision of
course that families may withdraw this consent at any
time). Ethical issues are discussed in greater depth
below, but we note at this point that in addition to
obtaining consent to access medical and social care re-
cords, the recruiter will be obliged to explicitly explain
the limits of confidentiality in the event that a child
protection concern arises. For those not consenting to
participate, we will nevertheless endeavour to obtain
anonymised summary data from primary care services
to characterise these cases, as prior work by our group
has found that these missing cases over-represent pop-
ulations in most need [71]. For any families that drop
out of the clinical project after randomisation, we will
endeavour to retain them in the research study in order
to minimise bias. In addition, even families who drop
out of the research study will be asked whether permis-
sion can remain to access their medical and social care
records so that data on child health outcomes can
nevertheless be obtained. Those who are allocated to
the treatment arm and later decide to withdraw from
the research will still be able to receive MTB treatment
if they wish to.
Randomisation
Eligible consenting participants will be randomised on a
1:1 basis by the randomisation centre (supervised by
Peter Fonagy) at a separate site, who will manage
randomisation. Monitoring of data quality and integrity
will be done separately by David Wellsted, study statisti-
cian. Together they will act as DMEC and will have
power to break confidential ID codes should ethical con-
cerns arise. A computer-generated adaptive minimisa-
tion algorithm [72] that incorporates a random element
will be used with the following balancing factors: treat-
ment centre, maternal age (below 20 versus 20 years or
older) and current depressive symptomatology (< 10 ver-
sus ≥ 10 on the EPDS). These minimisation factors have
been selected because previous research has shown that
these factors are associated with poorer outcomes on
some of our dependent measures or are highly plausible
treatment modifiers. Once a family has been approached
and has consented to take part, anonymised screening
data will be sent to the randomisation centre by the trial
coordinator. The randomisation centre will send the re-
sults of the randomisation to the local clinical manager
within 72 h, ensuring that the research team is fully
blind to the condition that the family is allocated to. Par-
ticipants will be informed about their group allocation,
as blinding to a psychosocial treatment of this nature is
not possible. The outcome assessors will be blind to the
participants’ allocation. During training, all research as-
sistants (RAs) will be briefed regarding the importance
of blindness to condition and they will record any in-
stances where the participating family discloses its con-
dition inadvertently, so that the impact of this can be
examined in the data analysis. Coding of the primary
outcome will be done independently from video record-
ings by raters who have no contact with the participants.
Planned intervention
Minding the Baby®
MTB is a home-visiting programme that helps vulner-
able or high-risk first-time mothers aged 14–25. The
programme has been developed by the Yale Child
Study Centre and the Yale School of Nursing, with the
main focus being on the parent-child relationship. The
MTB programme is delivered by an interdisciplinary
MTB team of highly skilled practitioners, a nurse or
health visitor experienced in parental, perinatal and
paediatric roles and a social worker or other suitably
trained practitioner trained in mental health assess-
ment and intervention.
Mothers are visited weekly at home from the third tri-
mester until the child’s first birthday and then fortnightly
until their second birthday. The two MTB practitioners’
visits are alternated weekly. Visits can be increased as re-
quired, particularly in times of crisis.
The health practitioner’s role will focus primarily, but
not exclusively, on the following:
Parental care and health education
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 Practitioners provide ongoing support and
information about maternal and infant nutrition
and healthy child growth and development,
including fetal and postnatal brain development.
Support is given regarding the prevention of
premature birth and planning for labour and
delivery. Practitioners also help pregnant women
to begin to anticipate and imagine life with a
newborn, what its needs might be, and how one
interacts and communicates with a young infant.
Practical and educational support is given to
women pre and postnatally regarding breast feeding
Child health and development
 The health practitioners undertake routine
assessments of the child’s physical, cognitive and
social development and provide advice and guidance
about the child health, including advice regarding
the identification and treatment of illnesses.
Practitioners also provide information and advice
about a safe environment for the child to reduce
incidents of injury. Finally, practitioners provide
anticipatory and ongoing guidance about parenting
of young infants and toddlers
Mother’s health
 Practitioners are trained to help women think about
safe sex and future family planning, provide support
and information regarding healthy lifestyles,
including smoking cessation support and healthy
nutrition and exercise. Practitioners also assist
mothers in obtaining support when they experience
physical or mental health difficulties (e.g. via
primary care) or have ongoing problems with stress
The social/therapeutic role focusses primarily but not
exclusively on the following:
Mental health promotion
 Practitioners in this role are trained in psychosocial
assessment and will gather a detailed: psychosocial
history; explore the mother’s feelings about her
pregnancy, her connection to her unborn child,
her own history of being raised and her expectations
about the parenting role. Practitioners are trained
to identify and provide intervention (through direct
working or signposting to others services as
appropriate) for mental health problems antenatally
and postnatally, and are able to provide focussed
mother-infant dyadic interaction guidance drawing
on principles from parent-infant psychotherapy,
and using video feedback to help mothers to attune
to the infant’s attachment cues and promote
sensitive interactions
Infant/child and family assessment and intervention
 As part of the dyadic work, practitioners also guide
mothers in dyadic play and provide developmental
guidance, helping to broaden mothers’ repertoire
of skills, teaching about typical developmental
milestones and facilitating mothers’ creativity in
parenting and self-efficacy. Where indicated, the
social-therapeutic practitioner will provide couples’
and family counselling and help families to manage
the complexities of formal, statutory/legal systems
such as housing, disputes around contact, or child
protection intervention. The practitioners offer a
broad range of support to help families manage
crises and provide assistance in supporting the
women’s acquiring of key life skills through
education and employment
Treatment as Usual (TAU)
TAU will be the standard care available in the local com-
munity, which will be determined by the needs of each
family and the local service provision. The first line of
services is provided at the primary care level by univer-
sally available professionals such as GPs, health visitors
and midwives. For individuals who require more sup-
port after birth the help they can receive will vary de-
pending on where they live and the degree of their
needs. In general, TAU is often a package of support
from family support workers, enhanced health visiting,
social worker or midwifery services (listening visits),
one-to-one support from clinical psychologists (pro-
vided through local CAMHS services), psychotherapists
or counsellors, postnatal support groups, crèches providing
respite, parenting education workshops, peer-supported
groups, home-visiting services, child psychiatry and family
therapy. The Service Users and Support (SUS) question-
naire will be used to check what usual care services both
groups of participants receive during the trial.
Intervention fidelity
Adherence to the MTB intervention protocol will be
achieved in close collaboration with the Yale team (in-
cluding the primary developers) in the following ways:
1. All participant contact will be guided by the
written intervention manual as well as other
training materials
2. All clinicians will receive extensive training in
the MTB model via in-person, taped, or
videoconference training sessions led by the Yale
MTB trainers. The Yale MTB trainers include
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senior nurse and mental health supervisors and
home visitors
3. All MTB practitioners will record detailed
information regarding their direct and indirect
contact with families
4. In order to ensure that home visits adhere to the
Yale MTB intervention programme after each visit
practitioners will complete a Home Visit Form.
This aims to describe the visits in detail and
compare them with the US MTB intervention home
visits. In particular practitioners record the length,
nature and focus of the visit and the families’ level
of engagement. It also summarises the focus of the
visit, e.g. parenting, health, mental health, etc., and
the time spent on each topic
5. Specially trained supervisors will undertake model
fidelity monitoring by random sampling of families
at each site and discussing the outcomes with the
relevant sites at compliance visits
6. All practitioners receive regular supervision by
Yale-trained local UK supervisors. These specially
trained supervisors meet monthly via phone with
the Yale MTB trainers
7. Regular disciplinary and interdisciplinary
supervision will be provided by specially trained
supervisors and the Yale MTB team (in addition
to supervision provided as usual by the
practitioners’ line managers)
Participant retention
Dropping out of treatment is common in prevention
studies in the perinatal period [73]. In one of the key
studies of the NFP programme, active refusals to partici-
pate in the trial ran at approximately 20 % (with a fur-
ther 20 % passively dropping out by not responding to
mailed invitations to participate), which is higher than
the estimates from the Yale pilot study [23]. However, it
is notable that a much smaller proportion refused to
participate in the research evaluation once they had
agreed to randomisation (3.8 %). From the outset of the
FNP study to the 2-year outcome phase a further 21 %
were lost to follow-up. In the UK, the FNP programme
had an initial uptake rate of 83 % of eligible families and
a later dropout rate of 15 %. We thus aim to over-
recruit by 15 % to take attrition into account, leading to
an initial intake target of N = 240, so that 100 per arm is
achieved at the year-2 outcome point. An overview of
participant timeline is presented in Table 2.
Data management
The data will be collected by experienced RAs who have
been trained to work with high-risk populations. Neces-
sary safeguarding policies will be in place to ensure the
safety of the RA collecting the data. In particular, contact
information of the assessment location will be left with
another member of staff before leaving for the assess-
ment. Regular contact with the RA will be maintained at
the start and end of the assessment. In situations where
an RA feels to be in immediate danger they will be
instructed to follow safeguarding policies to call the
police.
Regular supervision with the trial management team,
the coordinator and the principal investigators will en-
sure the reliability of data collection. Where necessary
the RAs will be fully trained and certified in administer-
ing and coding research measures.
All coding will be supervised by the principal investiga-
tors. Where standardised coding measures are required
the RAs will undertake full training courses and complete
necessary reliability checks. The data will be coded by an
RA who does not know the family and will be blind to the
subject status (intervention or control). Interrater reliabil-
ity will be established for all instruments.
Every week, questionnaire data collected the previous
week will be coded, verified and double-entered directly
into secure web databases. Audio interviews will be tran-
scribed and video-taped material downloaded, any per-
sonal identifiable information will be removed and the
data stored on a secure server ready for coding. To
check the reliability of the process, 10 % of the records
will be randomly selected and will be reviewed, coded
and entered independently by RAs for calculation of
interrater agreement rates. The databases will be com-
pared and checked for errors before transferring to an
SPSS (v. 21.0) file for analysis.
Data transfer
In the study, all participant data as outlined previously
in this protocol will be collected in accordance with the
participant Consent Form and Participant Information
Sheet. All participant data will be appropriately sent to
Dr. David Wellsted for statistical analysis and UCL will
act as the data controller of such data for the study. Pro-
fessor Pasco Fearon will be responsible for the process-
ing, storage and disposal of all participant data in
accordance with all applicable legal and regulatory re-
quirements, including the Data Protection Act 1998 and
any amendments thereto.
Data will be stored on a secure server dedicated ex-
clusively to this project that has encrypted access. Only
the research team will have access to the data and to
information identifying participants. Research data and
personally identifying data will be stored in separate,
web-accessible, secure databases. All research data will
be stored in locked filing cabinets in each site. Simi-
larly, Consent Forms will be stored separately from the
research data in locked filing cabinets in each site. Risks
to subject confidentiality will be minimised by adopting
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suitable data storage procedures in accordance with
best practice guidelines and in accordance with the
Data Protection Act. Subjects will be assigned ID num-
bers. The master ID list that links subject names with
ID numbers will be kept on a highly secure password-
protected server. All information concerning allocation
to condition (TAU or MTB) will be held securely by
the randomisation centre. Clinical records and other
relevant clinical information regarding participants in
the MTB arm will be held by the NSPCC, following
their standard governance protocols.
Data analysis
The primary outcome, maternal sensitivity, is an average
of several ordinal scores and is typically found to be ap-
proximately normally distributed. The primary analysis
will be a regression analysis testing group differences in
mean sensitivity at year 1 after adjustment for baseline
characteristics. Clustering by therapist and site will be
allowed for by computing robust standard errors [74].
Continuously distributed secondary outcomes will be
treated in the same manner. The risk of child protection
intervention will be described using the Kaplan-Meier
method and summarised by the proportions of children
with child protection intervention over 2 years period
of observation. The primary analysis for this outcome
will be Cox regression, adjusting for key baseline
characteristics.
Where there are missing data, these will be evaluated
either by multiple imputation or a sensitivity analysis
determined by the pattern of missing data. In doing so,
we will follow the procedures and guidance outlined by
Sterne and colleagues [75]. Mediational analyses of
change mechanisms (e.g. age 12 months’ maternal
sensitivity-mediating treatment effects on attachment at
age 2 years) will be tested using bootstrap methods de-
scribed by MacKinnon and Dwyer [76] and Preacher
and Hayes [77].
Additional data analysis
Economic evaluation
We will conduct a cost-effectiveness analysis of MTB
relative to the control condition from a broad societal
perspective.
Cost information: we propose two elements to the cost
component of the cost-effectiveness analysis:
1. Cost of MTB: this will include fixed costs associated
with the resources required to run the service as well
as variable costs associated with training, staffing and
related consumables. We will calculate a bottom-up
costing of the service and calculate a weighted cost
per case based on the caseload of each practitioner
2. Costs of the use of other resources: we will use a
self-completed Service User and Support (SUS)
questionnaire to collect other health and social care
and out-of-pocket costs for clients in the MTB and
the control group. The retrospective self-completed
questionnaire will provide information on resources
accessed during the last 6 months. The SUS will be
completed at enrolment, 6 months after the baby is
born by telephone and at each outcome assessment
(infant age 1 and 2 years). Resource use will be
costed using Personal Social Services Research Unit
(PSSRU) and national datasets wherever possible
We will provide summary statistics of the costs for the
MTB and the control group as well as a comparison of
the total cost per patient to society of MTB compared to
controls for the duration of the study.
Table 2 Time requirement per participant
Study period
Post allocation
Time point Prebaseline Baseline 6 months Year 1 18 months Year 2
Recruitment:
Eligibility screen X
Informed consent X
Allocation X
Research assessment:
Questionnaires X X X X X
Reflective Functioning X
Maternal sensitivity X X
Developmental assessment X
Attachment classification X X
Overall time involvement 15 min 1 h 15 min 2 h 15 min 2 h
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Incremental cost-effectiveness ratio (ICER): the ICER
is the mean cost per mother/child in the intervention
minus the mean cost per patient in the control group di-
vided by the mean incremental gain per mother/child in
outcomes from the intervention compared to the con-
trols. If an intervention has a lower cost to society and
better outcomes it is considered dominant and likely to
be adopted by a decision-maker if the evidence is satis-
factory. If the intervention has higher cost to society but
is associated with better outcomes the decision-maker
needs adequate information to determine if they are
willing to pay the additional cost per outcome gained.
We propose calculating a number of ICERs for MTB
compared to controls and propose using the following
outcomes in the denominator of the ICER for different
analyses:
 Maternal sensitivity
 Infant QoL using the Warwick Child Health
and Morbidity Profile [20, 78]
 Parental QoL using the EQ-5D, which is a brief
questionnaire that measures generic health-related
quality of life from the patient’s point of view.
EQ-5D scores can be converted to preference-based
utility scores that can be used to calculate
quality-adjusted life years (QALYs) for use in
cost-effectiveness analyses using an algorithm
developed by Dolan [67]
 Mother-infant attachment
As the ICER does not easily allow for normal statistical
tests we will use bootstrapping methods, replications of
the statistic of interest by sampling with replacement
from the original data, to calculate the confidence inter-
val for the ICER. We will also use this data and the net-
monetary benefit approach to calculate the probability
that MTB is cost-effective compared to the control
group for a number of values of willingness to pay per
gain in outcome or the cost-effectiveness acceptability
curve (CEAC) [19]. This provides more information to
decision-makers to help them decide if the outcomes
achieved as a result of the intervention are worth the
additional cost.
Lifetime model: poor parent-child relationships, child
abuse and neglect can have long-term negative impacts
on children, their families and society. Poor parenting
has repeatedly been identified as being associated with
antisocial behaviour and severe behavioural problems
[22, 23]. A long-term follow-up study of children with
conduct disorder suggested that the cost of unresolved
conduct disorders can exceed £1 million over an individ-
ual’s lifetime [2]. There are obviously further costs and
benefits to realise as a result of preventing each case of
child abuse and neglect. The ICERs proposed above do
not capture the full lifetime costs and outcomes that
may be realised as a result of MTB. As part of the pro-
ject we would, therefore, aim to investigate developing a
decision analytical model that uses information available
from the evaluation, as well as published data sources,
to determine the cost-effectiveness of MTB over the life-
time of the children.
Data monitoring
Data monitoring
The Trial Steering Committee (TSC) will take the role of
monitoring trial safety and data monitoring. The statisti-
cian will review the data on an ongoing basis, including
any adverse event records, and report this to the TSC.
Detailed reports will be prepared by the TSC statistician
to monitor safety/adverse event data, recruitment and
dropout rates. The formal statistical interim analysis of
the primary outcome will be reported to the TSC after
the end of the first outcome phase.
Trial Steering Committee
A TSC will be used to monitor the progress of the pro-
ject and advise the research team on matters arising dur-
ing subsequent phases of the study. The TSC will meet
6-monthly and perhaps more regularly during the pre-
paratory and final stages of the formal evaluation. The
group will be made up of representatives from the
NSPCC, researchers, a statistician, service users and/or
carers and representatives of professional/provider orga-
nisations, including a link person from at least two local
clinical teams.
Ethical considerations
This trial has received a multisite ethics approval from the
NHS Health Research Authority (NRES) Research Ethics
Committee (London-Dulwich, the United Kingdom) (REC
reference: 13/LO/1651; IRAS project ID: 135643; protocol
version 6.0, 11 January 2016). Research and Development
(R&D) approval is in place at all three sites. A formal
amendment is needed for any modification of the protocol
and requires approval by the NHS REC as well as the local
R&D office’s approval.
Discussion
The study protocol presented in this paper explains how
MTB, a programme aimed to support young, vulnerable
first-time parents with their baby, will be evaluated in a
randomised trial in the UK. A key feature of this ap-
proach is the way in which it combines health input
from community nurses with mental health input from
social workers. Another key feature is the explicit focus
on promoting sensitivity of parenting, and a model of
change based on the assumption, supported by develop-
mental research, that parental RF is critical in promoting
Longhi et al. Trials  (2016) 17:486 Page 13 of 16
sensitive and attuned interactions between mother and
infant. The trial represents the first UK study of MTB.
The MTB programme was developed at Yale University
where a pilot trial produced encouraging results [1]. Posi-
tive outcomes emerged in relation to attachment as well
as health and mental health outcomes. In particular, in-
fants allocated to the MTB group showed higher rates of
secure attachment, and mothers showed improvements in
maternal RF as well as positive health outcomes compared
to the control group. Crucially, these outcomes appeared
to be lasting as benefits continued to be observed when
the children were seen at the ages of 3 and 5 years.
We predict that similar outcomes will emerge from
this intervention in the UK. In particular, mothers ran-
domised to the MTB group, compared to the mothers in
the TAU group, are expected to show higher observed
sensitivity as well as more secure attachment. Findings
will be published in scientific journals, shared with
stakeholders and will inform child and maternal health
policy. The study will have important implications for
the delivery of early intervention to families who are po-
tentially at risk, especially during the crucial first months
and years of life, from pregnancy to age 2 years.
Trial status
Recruiting of expectant mothers started in April 2014
and we are still recruiting.
Additional file
Additional file 1: The SPIRIT checklist. (DOC 123 kb)
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